Kim Young-pill (third from right), a president of Green Cross Medical Science, a subsidiary of Korean biopharmaceutical company Green Cross, poses with foreign clients, who attended the conference held at its headquarters located in Yongin City on Thursday. (Green Cross Medical Science)
![[KH Explains] Naver’s Line dilemma: Lose global footing for cash?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/14/20240514050624_0.jpg)
